Proposed Data Collection Submitted for Public Comment and Recommendations, 73110-73112 [2016-25671]

Download as PDF 73110 Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Type of respondent Form name General responder ............................ Responder/Survivor/Advocate (physician). Postcard for new general responders in NY/NJ to select a clinic. Physician Request for Certification .. Denial Letter and Appeal Notification—Enrollment. Disenrollment Letter and Appeal Notification. Denial Letter and Appeal Notification—Health Condition Certification. Decertification Letter and Appeal Notification. Denial Letter and Appeal Notification—Treatment Authorization. WTC Health Program Medical Travel Refund Request. Form to designate a representative Form to share member information Outpatient prescription pharmaceuticals. Reimbursement Denial Letter and Appeal Notification. Petition for the addition of health conditions. Total ........................................... ........................................................... Program Medical Provider ................ Responder (FDNY and General Responder)/Survivor. Responder (FDNY and General Responder)/Survivor. Responder (FDNY and General Responder)/Survivor. Responder (FDNY and General Responder)/Survivor. Responder (FDNY and General Responder)/Survivor. Responder (FDNY and General Responder)/Survivor. Designated Rep Form ....................... HIPAA Release ................................. Pharmacy .......................................... Program Medical Provider ................ Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–25579 Filed 10–21–16; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–17–17AW; Docket No. CDC–2016– 0101] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on proposed and/or continuing information collections, as required by the Paperwork Reduction sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:42 Oct 21, 2016 Jkt 241001 Number of responses per respondent Number of respondents 1 15/60 619 20,000 45 1 1 30/60 30/60 10,000 23 3 1 30/60 1.5 60 1 90/60 90 5 1 90/60 7.5 26 1 90/60 39 10 1 10/60 2 10 10 150 1 1 261 15/60 15/60 1/60 3 3 653 600 1 30/60 300 60 1 60/60 60 ........................ ........................ ........................ 14,052 You may submit comments, identified by Docket No. CDC–2016– 0101 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Leroy A. Richardson, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change ADDRESSES: Frm 00055 Fmt 4703 Total burden hours 2,475 Act of 1995. This notice invites comment on the proposed information collection project entitled ‘‘Assessment of Targeted Training and Technical Assistance (TTA) Efforts on the Implementation of Comprehensive Cancer Control’’. CDC is requesting to collect information about TTA offered under two different cooperative agreements using case studies, a webbased survey, and in-depth interviews in order to document how TTA was provided and identify elements of TTA administered across both cooperative agreements that could inform the development of a viable TTA model for enhancing future tobacco and cancer prevention and control efforts. DATES: Written comments must be received on or before December 23, 2016. PO 00000 Average burden per response (in hours) Sfmt 4703 to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. Please note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the E:\FR\FM\24OCN1.SGM 24OCN1 Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review the collection of information; and to transmit or otherwise disclose the information. Proposed Project Assessing the Impact of Targeted Training and Technical Assistance Efforts on the Implementation of Comprehensive Cancer—NEW— National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention (CDC). sradovich on DSK3GMQ082PROD with NOTICES Background and Brief Description Cancer is the second leading cause of death in the United States, and health care costs for cancer care are expected to rise to $158 billion by 2020. Addressing this public health problem requires primary prevention, early detection and treatment, support for cancer survivors, and a reduction in health disparities. Providing support to state, tribal, territorial and local organizations to implement evidencebased strategies has the potential to impact population-level cancer outcomes and reduce the burden of cancer. VerDate Sep<11>2014 17:42 Oct 21, 2016 Jkt 241001 The Centers for Disease Control and Prevention’s (CDC) National Comprehensive Cancer Control Program (NCCCP) has been a primary funder for state and community-based cancer control interventions since its inception in the late 1990s. The program supports states and communities in developing a comprehensive approach to cancer prevention and control that includes supporting an infrastructure for state, local, and population-based interventions and multi-sectoral partnerships and coalitions. Currently, NCCCP supports 65 cancer control program grantees including programs in all 50 states, the District of Columbia, and in a number of tribes, tribal organizations, and U.S. Associated Pacific Islands/territories. In addition, CDC’s Office on Smoking and Health (OSH) also has worked to build state health department infrastructure and capacity to conduct coordinated comprehensive tobacco prevention and control activities which contribute to cancer health outcomes. In fiscal year 2015, OSH provided funding to a number of state health departments and local partners through the National State-Based Tobacco Control Program (NSTB) to support the implementation and evaluation of evidence-based environmental, policy, and systems interventions, strategies, and activities to reduce tobacco use, secondhand smoke exposure, tobacco-related disparities and associated disease, disability, and death. In striving to build capacity and maximize the impact of CDC’s funded programs, CDC has focused on developing and implementing innovative programs to enhance TTA delivered to NCCCP and NSBT grantee programs. CDC funds 10 programs under two cooperative agreements— Consortium of National Networks to Impact Populations Experiencing Tobacco-Related and Cancer Health Disparities (DP13–1314) and the National Support to Enhance Implementation of Comprehensive Cancer Control Activities (DP13–1315). These cooperative agreements provide funding to organizations to provide TTA to state NCCCP and NSBT grantees to support local implementation of highimpact public health strategies. DP13– 1314 awardees are charged with building the capacity of NCCCP and NSBT grantees through the administration of a national network to reduce the burden of cancer- and tobacco-related health disparities among vulnerable populations; DP13–1315 awardees are charged with delivering TTA to NCCCP programs and partners to enhance and facilitate local PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 73111 implementation of comprehensive cancer control (CCC) activities; policy, systems and environmental change strategies; effective public health partnership building; and promotion of CCC program successes and leverage additional resources for cancer control and prevention. These two TTA models aim to impact both short- and long-term outcomes on the awardee, NCCCP program, and population levels. CDC proposes to conduct an assessment of the DP13–1314 and DP13–1315 cooperative agreements to: (1) Increase CDC’s understanding of the TTA provided to NCCCP and NSTB grantees across both cooperative agreements, (2) help identify the extent to which core elements of the TTA were administered, and (3) determine the elements of TTA across both cooperative agreements that show promise for improving NCCCP and NSTB capacity. There are no other data collection efforts currently underway to assess implementation of the two TTA models or their perceived effectiveness among awardee programs. This information collection request will involve three complementary data collection efforts: (1) Case studies of DP13–1314 and DP13–1315 awardees (consisting of interviews with DP13– 1314 and DP13–1315 program managers/directors, evaluators, and partners); (2) a cross-sectional webbased survey administered to NCCCP and NSBT program directors, coalition members, and partners; and (3) in-depth interviews with NCCCP and NSBT program directors, staff, coalition members, and partners who received a high volume of TTA from one or more of the DP13–1314 and DP13–1315 awardees. The case studies will be used to explore how DP13–1314 and DP13– 1315 awardees are implementing their respective cooperative agreements and administering TTA to NCCCP and NSBT grantees; the factors that affect the implementation of specific TTA components; and the extent to which each cooperative agreement was able to achieve planned short-term outcomes. The web-based survey will inform CDC’s understanding of the reach of DP13–1314 and DP13–1315 TTA efforts; elicit information from NCCCP and/or NSBT programs and coalitions about the TTA received, including type, dosage, frequency and format; and assess the perceptions of the effectiveness of the TTA provided in building capacity to achieve intended outcomes. The indepth interviews with ‘‘high-volume’’ TTA users will facilitate an in-depth exploration of the type and quality of TTA activities received; perceived quality of TTA and its contributions to E:\FR\FM\24OCN1.SGM 24OCN1 73112 Federal Register / Vol. 81, No. 205 / Monday, October 24, 2016 / Notices NCCCP and NSBT grantee program implementation, and achievement of CDC priorities and goals. CDC will use findings from the assessment to inform development of future TTA efforts that utilize the core elements across the two models to more effectively and efficiently support NCCCP’s partner organizations. CDC seeks a two-year approval to collect the required information. Participation is voluntary and respondents will not receive incentives for participation. There are no costs to respondents other than their time. ESTIMATED ANNUALIZED BURDEN HOURS Form name DP13–1314 and DP13–1315 Awardee Organizations. DP13–1314 Program Directors/Managers. Worksheet for Identifying Case Study Interviewees. Case Study Interview Guide for DP13–1314 Program Managers. Case Study Follow-Up Interview Guide for DP13–1314 Program Managers. Case Study Interview Guide for DP1–1315 Program Managers. Case Study Follow-Up Interview Guide for DP1–1315 Program Managers. Case Study Interview Guide for DP1–1314 Evaluators. Case Study Interview Guide for DP1–1315 Evaluators. Case Study Interview Guide for DP1–1314 Partners. Case Study Interview Guide for DP1–1315 Partners. Survey .............................................. NSBT Program DirecPartners, and Coalition Total ........................................... DP13–1315 Program Directors/Managers. DP13–1314 Evaluators ..................... DP13–1315 Evaluators ..................... DP13–1314 Partners ........................ DP13–1315 Partners ........................ NCCCP and tors, Staff, Members. NCCCP and tors, Staff, Members. NSBT Program DirecPartners, and Coalition 60/60 10 16 1 90/60 24 16 1 60/60 16 4 1 90/60 6 4 1 60/60 4 16 1 60/60 16 4 1 60/60 4 32 1 60/60 32 8 1 60/60 8 1560 1 15/60 390 TTA Recipient Interview Guide ........ 10 1 30/60 5 ........................................................... ........................ ........................ ........................ 515 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30 Day–17–16AVC] Agency Forms Undergoing Paperwork Reduction Act Review sradovich on DSK3GMQ082PROD with NOTICES Total burden (in hours) 1 [FR Doc. 2016–25671 Filed 10–21–16; 8:45 am] The Centers for Disease Control and Prevention (CDC) has submitted the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The notice for the proposed information collection is 17:42 Oct 21, 2016 Average burden per response (in hours) 10 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. VerDate Sep<11>2014 Number of responses per respondent Number of respondents Type of respondents Jkt 241001 published to obtain comments from the public and affected agencies. Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address any of the following: (a) Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) Evaluate the accuracy of the agencies estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (c) Enhance the quality, utility, and clarity of the information to be collected; (d) Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 responses; and (e) Assess information collection costs. To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call (404) 639–7570 or send an email to omb@cdc.gov. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, Washington, DC 20503 or by fax to (202) 395–5806. Written comments should be received within 30 days of this notice. Proposed Project CDC/ATSDR Formative Research and Tool Development—New — Office of the Director, Centers for Disease Control and Prevention (CDC). Background and Brief Description The Centers for Disease Control and Prevention requests approval for a new generic information collection plan entitled CDC/ATSDR Formative Research and Tool Development. This E:\FR\FM\24OCN1.SGM 24OCN1

Agencies

[Federal Register Volume 81, Number 205 (Monday, October 24, 2016)]
[Notices]
[Pages 73110-73112]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25671]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-17-17AW; Docket No. CDC-2016-0101]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing efforts to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies to take this opportunity to comment on proposed and/or 
continuing information collections, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on the proposed 
information collection project entitled ``Assessment of Targeted 
Training and Technical Assistance (TTA) Efforts on the Implementation 
of Comprehensive Cancer Control''. CDC is requesting to collect 
information about TTA offered under two different cooperative 
agreements using case studies, a web-based survey, and in-depth 
interviews in order to document how TTA was provided and identify 
elements of TTA administered across both cooperative agreements that 
could inform the development of a viable TTA model for enhancing future 
tobacco and cancer prevention and control efforts.

DATES: Written comments must be received on or before December 23, 
2016.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0101 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Leroy A. Richardson, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road, 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.
    Please note: All public comment should be submitted through the 
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the 
address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION:  Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the

[[Page 73111]]

collection to OMB for approval. To comply with this requirement, we are 
publishing this notice of a proposed data collection as described 
below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Assessing the Impact of Targeted Training and Technical Assistance 
Efforts on the Implementation of Comprehensive Cancer--NEW--National 
Center for Chronic Disease Prevention and Health Promotion, Centers for 
Disease Control and Prevention (CDC).

Background and Brief Description

    Cancer is the second leading cause of death in the United States, 
and health care costs for cancer care are expected to rise to $158 
billion by 2020. Addressing this public health problem requires primary 
prevention, early detection and treatment, support for cancer 
survivors, and a reduction in health disparities. Providing support to 
state, tribal, territorial and local organizations to implement 
evidence-based strategies has the potential to impact population-level 
cancer outcomes and reduce the burden of cancer.
    The Centers for Disease Control and Prevention's (CDC) National 
Comprehensive Cancer Control Program (NCCCP) has been a primary funder 
for state and community-based cancer control interventions since its 
inception in the late 1990s. The program supports states and 
communities in developing a comprehensive approach to cancer prevention 
and control that includes supporting an infrastructure for state, 
local, and population-based interventions and multi-sectoral 
partnerships and coalitions. Currently, NCCCP supports 65 cancer 
control program grantees including programs in all 50 states, the 
District of Columbia, and in a number of tribes, tribal organizations, 
and U.S. Associated Pacific Islands/territories.
    In addition, CDC's Office on Smoking and Health (OSH) also has 
worked to build state health department infrastructure and capacity to 
conduct coordinated comprehensive tobacco prevention and control 
activities which contribute to cancer health outcomes. In fiscal year 
2015, OSH provided funding to a number of state health departments and 
local partners through the National State-Based Tobacco Control Program 
(NSTB) to support the implementation and evaluation of evidence-based 
environmental, policy, and systems interventions, strategies, and 
activities to reduce tobacco use, secondhand smoke exposure, tobacco-
related disparities and associated disease, disability, and death.
    In striving to build capacity and maximize the impact of CDC's 
funded programs, CDC has focused on developing and implementing 
innovative programs to enhance TTA delivered to NCCCP and NSBT grantee 
programs. CDC funds 10 programs under two cooperative agreements--
Consortium of National Networks to Impact Populations Experiencing 
Tobacco-Related and Cancer Health Disparities (DP13-1314) and the 
National Support to Enhance Implementation of Comprehensive Cancer 
Control Activities (DP13-1315). These cooperative agreements provide 
funding to organizations to provide TTA to state NCCCP and NSBT 
grantees to support local implementation of high-impact public health 
strategies. DP13-1314 awardees are charged with building the capacity 
of NCCCP and NSBT grantees through the administration of a national 
network to reduce the burden of cancer- and tobacco-related health 
disparities among vulnerable populations; DP13-1315 awardees are 
charged with delivering TTA to NCCCP programs and partners to enhance 
and facilitate local implementation of comprehensive cancer control 
(CCC) activities; policy, systems and environmental change strategies; 
effective public health partnership building; and promotion of CCC 
program successes and leverage additional resources for cancer control 
and prevention. These two TTA models aim to impact both short- and 
long-term outcomes on the awardee, NCCCP program, and population 
levels.
    CDC proposes to conduct an assessment of the DP13-1314 and DP13-
1315 cooperative agreements to: (1) Increase CDC's understanding of the 
TTA provided to NCCCP and NSTB grantees across both cooperative 
agreements, (2) help identify the extent to which core elements of the 
TTA were administered, and (3) determine the elements of TTA across 
both cooperative agreements that show promise for improving NCCCP and 
NSTB capacity. There are no other data collection efforts currently 
underway to assess implementation of the two TTA models or their 
perceived effectiveness among awardee programs.
    This information collection request will involve three 
complementary data collection efforts: (1) Case studies of DP13-1314 
and DP13-1315 awardees (consisting of interviews with DP13-1314 and 
DP13-1315 program managers/directors, evaluators, and partners); (2) a 
cross-sectional web-based survey administered to NCCCP and NSBT program 
directors, coalition members, and partners; and (3) in-depth interviews 
with NCCCP and NSBT program directors, staff, coalition members, and 
partners who received a high volume of TTA from one or more of the 
DP13-1314 and DP13-1315 awardees. The case studies will be used to 
explore how DP13-1314 and DP13-1315 awardees are implementing their 
respective cooperative agreements and administering TTA to NCCCP and 
NSBT grantees; the factors that affect the implementation of specific 
TTA components; and the extent to which each cooperative agreement was 
able to achieve planned short-term outcomes. The web-based survey will 
inform CDC's understanding of the reach of DP13-1314 and DP13-1315 TTA 
efforts; elicit information from NCCCP and/or NSBT programs and 
coalitions about the TTA received, including type, dosage, frequency 
and format; and assess the perceptions of the effectiveness of the TTA 
provided in building capacity to achieve intended outcomes. The in-
depth interviews with ``high-volume'' TTA users will facilitate an in-
depth exploration of the type and quality of TTA activities received; 
perceived quality of TTA and its contributions to

[[Page 73112]]

NCCCP and NSBT grantee program implementation, and achievement of CDC 
priorities and goals.
    CDC will use findings from the assessment to inform development of 
future TTA efforts that utilize the core elements across the two models 
to more effectively and efficiently support NCCCP's partner 
organizations.
    CDC seeks a two-year approval to collect the required information. 
Participation is voluntary and respondents will not receive incentives 
for participation. There are no costs to respondents other than their 
time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent      (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
DP13-1314 and DP13-1315         Worksheet for                 10               1           60/60              10
 Awardee Organizations.          Identifying
                                 Case Study
                                 Interviewees.
DP13-1314 Program Directors/    Case Study                    16               1           90/60              24
 Managers.                       Interview Guide
                                 for DP13-1314
                                 Program
                                 Managers.
                                Case Study                    16               1           60/60              16
                                 Follow-Up
                                 Interview Guide
                                 for DP13-1314
                                 Program
                                 Managers.
DP13-1315 Program Directors/    Case Study                     4               1           90/60               6
 Managers.                       Interview Guide
                                 for DP1-1315
                                 Program
                                 Managers.
                                Case Study                     4               1           60/60               4
                                 Follow-Up
                                 Interview Guide
                                 for DP1-1315
                                 Program
                                 Managers.
DP13-1314 Evaluators..........  Case Study                    16               1           60/60              16
                                 Interview Guide
                                 for DP1-1314
                                 Evaluators.
DP13-1315 Evaluators..........  Case Study                     4               1           60/60               4
                                 Interview Guide
                                 for DP1-1315
                                 Evaluators.
DP13-1314 Partners............  Case Study                    32               1           60/60              32
                                 Interview Guide
                                 for DP1-1314
                                 Partners.
DP13-1315 Partners............  Case Study                     8               1           60/60               8
                                 Interview Guide
                                 for DP1-1315
                                 Partners.
NCCCP and NSBT Program          Survey..........            1560               1           15/60             390
 Directors, Staff, Partners,
 and Coalition Members.
NCCCP and NSBT Program          TTA Recipient                 10               1           30/60               5
 Directors, Staff, Partners,     Interview Guide.
 and Coalition Members.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             515
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-25671 Filed 10-21-16; 8:45 am]
BILLING CODE 4163-18-P